Pharmaceutical News

RSS

New protocol for HIV prevention drug reduces the number of pills required

Health officials and AIDS advocates in San Francisco hope to expand the use of an effective HIV prevention drug with a new approach that requires fewer pills than the standard once-a-day regimen.

29 Jul 2019

GOP senators distance themselves from Grassley and Trump’s efforts to cut drug prices

The fight between policymakers intent on lowering prescription drug prices and the drugmakers who keep raising them intensified Thursday, as a slew of Republican senators threatened to side with manufacturers against legislation supported by their own committee chairman and president.

25 Jul 2019

KHN’s ‘What the Health?’: Cue the drug price debate

The Republican and Democratic leaders of the Senate Finance Committee this week unveiled a sweeping proposal that seeks to lower prescription drug prices for the Medicare and Medicaid programs.

25 Jul 2019

Fungus used in traditional medicine could slow neuron loss in ALS

A Chinese caterpillar fungus that is used in traditional Chinese medicine has been found to minimize motor neuron loss in mice models of ALS.

25 Jul 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

Summer setbacks: The long road to lower drug prices hits some potholes

When Washington returned from its winter holiday break in January, it seemed everyone was talking about lowering drug prices.

24 Jul 2019

New vaccine containing DNA and recombinant proteins may protect from HIV

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins?proteins composed of a portion of an HIV protein and another unrelated protein.

24 Jul 2019

Folic acid supplementation mitigates risk of neural tube defects linked to HIV drug

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation.

24 Jul 2019

Patients have higher risk of heart problems when insurance companies reject their prescriptions

Patients appear to be at higher risk of heart problems or stroke when prescriptions for the newest cholesterol-lowering drugs are rejected by insurance companies or unfilled by patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

23 Jul 2019

FDA grants approval for generic versions of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.

22 Jul 2019

Marijuana use before and during pregnancy has increased over time, finds study

An observational study of pregnant women in Northern California suggests marijuana use before and during pregnancy has increased over time.

22 Jul 2019

New EU-funded project helping to develop safer, more effective medicines

Chiral pharmaceuticals are widely used in clinical treatments and agriculture. They include non-steroid anti-inflammatory drugs, Î²-blockers for reducing blood pressure, and herbicides and pesticides.

22 Jul 2019

Understanding how anti-malarial drug primaquine works lead to more effective malarial therapies

Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine works, which they hope will lead to the development of new, safer and more effective treatments for malaria.

22 Jul 2019

Some pharmacists not adhering to therapeutic guidelines, QUT study finds

As the role of pharmacies in providing front-line public health services grows, a QUT study has raised concerns that some are not adhering to therapeutic guidelines when distributing pharmaceuticals.

19 Jul 2019

Some pharmacists fail to adhere to therapeutic guidelines, highlights study

As the role of pharmacies in providing front-line public health services grows, a QUT study has raised concerns that some are not adhering to therapeutic guidelines when distributing pharmaceuticals.

19 Jul 2019

Diabetes medications mask euglycemic ketoacidosis at the time of surgery

A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery.

18 Jul 2019

Human genotype determines if a given Alzheimer's drug will be effective

University at Buffalo researchers have determined that a human gene present in 75 % of the population is a key reason why a class of drugs for Alzheimer's disease seemed promising in animal studies only to fail in human studies.

18 Jul 2019

Over 1 million years of life lost in Ohio from overdose deaths, shows study

The drug addiction epidemic continues to plague the country, and thousands of lives are cut short each year due to overdose.

18 Jul 2019

Study explores pregnancy-related adverse events associated with acne medication

Isotretinoin (also known by its former brand name as Accutane or Roaccutane) is an extremely effective acne medication that can help patients whose severe acne has not responded to other drugs.

17 Jul 2019

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

17 Jul 2019